RUBIN JONATHAN (SVP, Chief Medical Officer) received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/27/2024ACC: 0001104659-24-028272
Officer· SVP, Chief Medical Officer
Since Jan 2021
-567.00
Net shares
Net seller
$16.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.25K acquired · 1.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.25K
Price / share
—
Trade value
—
% of position
31.6%
2/23/2024
3.96K→5.21K
Common Stock
Direct
Shares
−567.00
Price / share
$29.06
Trade value
$16.48K
% of position
10.9%
2/23/2024
5.21K→4.64K
Total
Net shares
+683.00
Net value
-$16.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2024 | A · Award | +1.25K | — | — | 31.6% | 3.96K | 5.21K |
| Common Stock Direct | 2/23/2024 | F · Tax Withholding | −567.00 | $29.06 | $16.48K | 10.9% | 5.21K | 4.64K |
| Total | +683.00 | -$16.48K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.25K shares
Shares
−1.25K
Strike price
Held after
3.75K
Exercisable
—
2/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.25K shares | 2/23/2024 | D · Disposition | −1.25K | — | 3.75K |